Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1992-11-20
1995-05-02
Russel, Jeffrey E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
A61K 3736
Patent
active
054119510
ABSTRACT:
Prolonged parenteral release of a bioactive polypeptide at desirably effective levels can be achieved using novel compositions in which the polypeptide is present in a biocompatible oil in an unusually high proportion such as at least about 10% by weight. Also disclosed are certain metal-associated somatotropins that are useful for prolonged parenteral release of such somatotropins.
REFERENCES:
patent: 2491537 (1949-12-01), Welsch
patent: 2493202 (1950-01-01), Macek
patent: 2661315 (1953-12-01), Juriat et al.
patent: 2690414 (1954-09-01), Buckwalter
patent: 2807569 (1957-09-01), Homan et al.
patent: 2902408 (1959-09-01), Bouman et al.
patent: 3118815 (1964-01-01), Li
patent: 3678027 (1972-07-01), De Jager et al.
patent: 3810881 (1974-05-01), Rittel et al.
patent: 3869549 (1975-03-01), Geller
patent: 4172138 (1979-10-01), Rhodes
patent: 4256737 (1981-03-01), Nestor
patent: 4279547 (1981-07-01), Clem
patent: 4310516 (1982-01-01), Chang et al.
patent: 4328214 (1982-05-01), Rink et al.
patent: 4343789 (1982-08-01), Kawata et al.
patent: 4358439 (1982-11-01), Sieber et al.
patent: 4388307 (1983-06-01), Cavanak
patent: 4452775 (1984-06-01), Kent
patent: 4526938 (1985-07-01), Churchill
patent: 4659696 (1987-04-01), Hirai et al.
patent: 4670419 (1987-06-01), Uda et al.
patent: 4673641 (1987-06-01), George et al.
patent: 4968703 (1990-11-01), Humphrey et al.
patent: 5013713 (1991-05-01), Mitchell
patent: 5086041 (1992-02-01), Mitchell
"Continuous Elevation of Blood Growth Hormone Concentrations by Beeswax Implant" Davis et al. J. Dairy Science 66 1980-1982 (1983).
"The Development, Evaluation and Clinical Use of Long-Acting ACTH Preparations" Wolfson et al. Proceedings of Second Clinical ACTH Conference, vol. II, Part I, pp. 1-29 (1951).
Moore et al., 34 Int'l. J. Pharm. 35-43 (1986) at p. 37.
"The Effect of Exogenous Vasopressin and Growth Hormone on the Growth of Rats with Hereditary Hypothalmic Diabetes Insipidus", Growth 37:127-142 (1973) Sokol & Sise.
"Growth Hormone Release Inhibiting Hormone in Acromegaly", Brit. Med. J. 2:352-355 (1974), Besser et al.
"The Development, Evaluation, and Clinical Use of Long-Acting ACTH Preparations", Proc. of the Second Clinical ACTH Conf., J. R. Mote, ed., pp. 1-29 (1951), Wolfson, et al.
"An Excellently Tolerated, Heat-Stable, Long Acting ACTH Preparation Suitable for Prolonged & Ambulatory Treatment", Abstracts of Papers of Thirty-Third Meeting: 11, p. 800 (1952), W. Wolfson et al.
"A Comparison of the Duration of Action of Various Long-Acting ACTH Preparations in Human Subjects", New Eng. Journ. Med. 246:1000-1004 (1952) W. Wolfson and S. Fajans.
"Assay of ACTH on the Thymus of the Nestling Rat", Lancet, pp. 790-793 (1952), Bruce, A. Parkes.
"The Three Subtypes of Adrenocorticotropin", AMA Archives of Internal Med pp. 108-147 (ca. 1953), W. Wolfson.
"Correlation of ACTH Assays", Endocrinol. 52:496-509 (1953), Thompson and Fisher.
"Sustained Release of Parenteral Drugs", Bulletin of Parenteral Drug Assoc., pp. 6-16 (1960), Thompson.
"The Probability the Increased Secretion of Oxysteroids Does Not Fully Explain Improvement in Certain Systemic Diseases During Pregnancy" JMSMS, pp. 1019-1022 (1952), W. Wolfson et al.
"The Effect of Vehicle and Particle Size on the Absorption of the Intramuscular Route of Procaine Penicillin G Suspension" J. Amer. Pharm. Assn. XLVII:661-666 (1958), Buckwalter and Dickison.
"Studies on Long-Acting Vitamin B12 Preparation", Amer. J. Clin. Nutrition 7:311-317 (1959), Thompson and Hecht.
"The Pharmaceutical Suspension, Part 1" Drug & Cosmetic Industry, 97 (1965), R. Nash.
"The Pharmaceutical Suspension, Part 2" Drug & Cosmetic Industry, 98 (1966), R. Nash.
"Parenteral Suspensions", Bulletin of Parenteral Drug Assoc. 26:91-95 (1972), R. Nash.
"The Formulation of Parenteral Products", Parenteral Products, pp. 14-47 (1973), M. Groves.
"Long-Acting Parenteral Drug Formulations", Jour. Parenteral Sci. & Tech. 35:281-284 (1981) Y. Chien.
"Novel Drug Delivery Systems", pp. 219-247, (1982), Y. Chien Syringeability of Nonaqueous Parenteral Formulations--Development and Evaluation of a Testing Apparatus, J. Parenteral Sci. and Technol. 35:281-284, Y. Chien.
"Aluminum Carboxylates" in Encyclopedia of Chemical Technology, Kirk and Ottmer (1978), Warner.
"Use of Growth Hormone Gel", Archives of Disease in Childhood 54:609-613 (1979), Lippe et al.
"Recent Advances in Parenteral Drug Delivery Systems", J. Parenteral Sci. and Technol. 37:20-25 (1983), Fara.
"The Potential Use of Cyclodextrins in Parenteral Formulations", Journal of Parenteral Science and Technology, vol. 43, No. 5, 231-240 (1989) M. E. Brewster et al. 1070.
"Use of 2-Hydroxypropyl-.beta.-cyclodextrin as a Solubilizing and Stabilizing Excipient for Protein Drugs" Pharmaceutical Research, vol. 8 No. 6 (1991) 792-795, M. E. Brewster et al.
"Effect of Bovine Growth Hormone Administered in Various Patterns on Nitrogen Metabolism in the Holstein Steer" J. Animal Science 55, 5, 1982, pp. 1062-1070, W. M. Moseley et al.
"Comparison of Different Patterns of Exogenous Growth Hormone Administration on Milk Production in Holstein Cows", J. Animal Science 57, 3, 1983, pp. 699-705, Thomas J. Fronk et al.
Remington's Pharmaceutical Sciences, 16th Ed. 1980, pp. XIII and 1609/1610.
The Concise Oxford Dictionary, 1976, p. 801.
"Estimation of Growth Hormone Secretion Rate in Cattle", J. Animal Science 29 (1969), pp. 341-344, M. K. Youself et al.
"Effect of Placental Gonadotropin on Pregnancy Rate in the Bovine", J. Animal Science 36, 6, 1973, pp. 1129-1136, J. F. Wagner et al.
Physical Pharmaceutics--E. Shotton & K. Ridgway, Clarenden Press, Oxford, 1974, pp. 69 and 70.
"Long-Acting Parenteral Drug Formulations", J. Parenteral Science and Technology, vol. 15, No. 3, 1981, pp. 106-139, Yie W. Chien.
"Effect of Growth Hormone on Milk Production and Feed Utilization in Dairy Cows", J. Dairy Science 56(5), 575-580 (1973), L. J. Machlin.
Dispensing of Medication, Ed. Hoover, 39-85 (1976).
Drug Design, vol. 4, Ariens, 75-92 (1973), particularly Table 1, p. 87.
Formulation of Veterinary Dosage Forms, vol. 17, Ed. Blodinger, 1-70 (1983).
Davis et al., J. Dairy Sciences (1983) 66:1980-82.
Remington's Pharmaceutical Sciences, 16th Ed., Mack Publishing Co., Easton, Pa. 1980, pp. 1609-1610.
Banker & Rhodes, Modern Pharmaceutics, Marcel Dekker, Inc., New York and Basel, pp. 458-460 (date not shown).
Galenica 2 Biopharmacie, Paris, 1978, pp. 517-518.
Drug Design, vol. 4, Ariens, 75-92 (1973).
Formulation of Veterinary Dosage Forms, vol. 17, Ed. Blodinger, 1-70 (1983), particularly p. 51.
Journal of Parenteral Science and Technology, vol. 43, No. 5, 231-240 (1989), M. E. Brewster et al., "The Potential Use of Cyclodextrins in Parenteral Formulations".
J. Animal Science 55,5, 1982, pp. 1062-1070, W. M. Moseley et al., "Effect of Bovine Growth Hormone Administered in Various Patterns on Nitrogen Metabolism in the Holstein Steer".
J. Parenteral Science and Technology, vol. 35, No. 3, 1981, pp. 106-139, Yie W. Chien, "Long-Acting Parenteral Drug Formulations".
Beck George R.
Bond Gary M.
Monsanto Company
Russel Jeffrey E.
LandOfFree
Prolonged release of biologically active somatotropin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prolonged release of biologically active somatotropin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prolonged release of biologically active somatotropin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1137155